Effects of a combination supplement containing Lysine, Vitamin C and Zinc on oxidative stress, glycaemic control and formation of Advanced Glycosylation End Products (AGEs) in patients with type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical trial

Dr. Jhon Burd0 个研究点开始时间: 待定最近更新: 2024年8月20日

适应症

试验速览

暂无简介。

•a) Age between 20-70 years
•b) Both male and female
•c) Currently on metformin or sulphonyluria or both (less than or equal to two oral hypoglcaemic agents) for the last 3 months
•d) HbA1c > 7.5%

•a) Patients with allergy to any ingredients of the supplement.
•b) Alcohol consumption >20g/day.
•c) Patients with diagnosed Alcoholic Liver Disease, cirrhosis or abnormal baseline liver function tests.
•d) Patients on insulin therapy.
•e) Patients with raised baseline serum creatinine level (>1.5mg/dl in males or >1.2 mg/dl in females).
•f) Lactation, pregnancy or unwillingness to use an effective form of birth control for women of childbearing years.
•g) Patients with any malignancy.
•h) Patients with any other unrelated chronic illness.
•i) Patients with cardiac, liver or respiratory failure.
•j) Patients on any other vitamin/mineral supplementations or any other weight loss medication.
•k) Any condition in the opinion of the primary investigator that would contraindicate the patient's participation.

发起方

Dr. Jhon Burd